— Know what they know.
Not Investment Advice
Also trades as: COLO-B.CO (CPH) · $vol 22M · CLPBY (OTC) · $vol 2M · CBHD.DE (XETRA) · $vol 0M

CLPBF OTC

Coloplast A/S
1W: +0.0% 1M: -8.1% 3M: +3.9% YTD: -25.0% 1Y: -23.2% 3Y: -38.0% 5Y: -58.4%
$62.81
+0.00 (+0.00%)
 
OTC · Healthcare · Medical - Instruments & Supplies · Tech Score Strong Sell · Power 43 · $13.0B mcap · 143M float · 0.0009% daily turnover · Short 90% of daily vol
Smart Money Score
No convergence signal
Key Statistics
Market Cap$13.0B
52W Range56.81-95.43
Volume3
Avg Volume1,346
Beta0.55
Dividend$3.58
Analyst Ratings
1 Buy 0 Hold 0 Sell
Consensus Buy
Company Info
CEOGavin Wood
Employees16,907
SectorHealthcare
IndustryMedical - Instruments & Supplies
IPO Date2000-08-09
Holtedam 1
Humlebæk, ZE 3050
DK
45 49 11 11 11
About Coloplast A/S

Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Dressings and Biologics segments. It provides ostomy care products, including SenSura Mio, which provides fit individual body shapes and discretion for various types of ostomies; and SenSura Ostomy care solutions, as well as ostomy accessories under the Brava brand. The company also offers continence care products, such as Conveen Active urine bags; SpeediCath catheters that offer catheterization for both genders; Peristeen Plus, a transanal irrigation system; and Peristeen Light, a low-volume transanal irrigation. In addition, it provides wound care products comprising conforming dressing under the Biatain Silicone brand and hydrocolloid dressing under the Comfeel brand. Further, the company develops, produces, and markets products for the surgical treatment of urological and gynecological disorders, such as erectile dysfunction, urinary stone diseases, benign prostate hyperplasia, voiding dysfunctions, and urinary incontinence. Additionally, its voice and respiratory care solutions include laryngectomy care products comprising Provox, a voice prosthesis for speaking, HMEs, adhesives, laryngectomy tubes for breathing, devices for speaking hands-free, and accessories, as well as tracheostomy care products under Tracoe brand. Coloplast A/S was founded in 1954 and is headquartered in Humlebæk, Denmark.

Recent Insider Trades

No insider trades found

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms